Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma

NCT01269437 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

332

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Budesonide dry powder inhaler

Sponsor

NovaMed Pharmaceuticals Inc.